Philips | PHIA - Cash And Equivalent


Philips reported EUR1.79B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
ABB USD 3.87B 542M Jun/2026
Abbott USD 6.8B 1.72B Mar/2026
Aena EUR 1.39B 1.56B Jun/2026
Alcon AG USD 1.58B 80M Mar/2026
ASM International NV EUR 1.18B 198.5M Jun/2026
ASML Holding EUR 6.67B 1.3B Jun/2026
AstraZeneca USD 4.89B 2.67B Jun/2026
Bayer EUR 6.67B 774M Dec/2025
Boston Scientific USD 539M 914M Jun/2026
Demant DKK 1.33B 188M Dec/2025
EDAP TMS EUR 15.01M 14.82M Mar/2026
Edwards Lifesciences USD 2.9B 500M Jun/2026
Essilor EUR 3.54B 758M Dec/2025
Fresenius EUR 1.31B 81M Dec/2025
Fresenius Medical Care EUR 1.24B 343.37M Mar/2026
Geberit CHF 403.6M 4.1M Mar/2025
Getinge SEK 2.05B 909M Jun/2026
GN Store Nord DKK 1.12B 352M Dec/2025
GRIFOLS EUR 513M 189M Jun/2026
HeidelbergCement EUR 2.54B 1.21B Dec/2025
Intuitive Surgical USD 8.63B 646.3M Jun/2026
Koninklijke Philips EUR 2.59B 680M Mar/2026
Legrand EUR 1.96B 23.7M Jun/2026
Lonza CHF 719M 188M Dec/2025
Medtronic USD 1.15B 135M Dec/2025
Merck EUR 2.33B 77M Dec/2025
Philips EUR 1.79B 803M Jun/2026
Sanofi EUR 6.35B 806M Jun/2026
SAP EUR 10.04B 1.83B Mar/2026
Schneider Electric EUR 4.63B 621M Dec/2025
Trinity Biotech USD 5.14M 3.8M Dec/2025